U.S. flag

An official website of the United States government

NM_000263.4(NAGLU):c.1006G>T (p.Glu336Ter) AND multiple conditions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 20, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003766125.1

Allele description [Variation Report for NM_000263.4(NAGLU):c.1006G>T (p.Glu336Ter)]

NM_000263.4(NAGLU):c.1006G>T (p.Glu336Ter)

Gene:
NAGLU:N-acetyl-alpha-glucosaminidase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q21.2
Genomic location:
Preferred name:
NM_000263.4(NAGLU):c.1006G>T (p.Glu336Ter)
HGVS:
  • NC_000017.11:g.42541191G>T
  • NG_011552.1:g.10259G>T
  • NM_000263.4:c.1006G>TMANE SELECT
  • NP_000254.2:p.Glu336Ter
  • NC_000017.10:g.40693209G>T
  • NM_000263.3:c.1006G>T
Protein change:
E336*
Links:
dbSNP: rs376090795
NCBI 1000 Genomes Browser:
rs376090795
Molecular consequence:
  • NM_000263.4:c.1006G>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Mucopolysaccharidosis, MPS-III-B (MPS3B)
Synonyms:
NAGLU DEFICIENCY; Mucopoly-saccharidosis type 3B; Sanfilippo syndrome B; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009656; MedGen: C0086648; OMIM: 252920
Name:
Charcot-Marie-Tooth disease axonal type 2V
Synonyms:
CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2V; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2V
Identifiers:
MONDO: MONDO:0014665; MedGen: C5569050; Orphanet: 447964; OMIM: 616491

Recent activity

  • SRX2635342 (1)
    SRA
  • DNA mismatch repair protein MutS [Lysobacter sp. HDW10]
    DNA mismatch repair protein MutS [Lysobacter sp. HDW10]
    gi|1821135702|gnl|PRJNA609858|G7069 5|gb|QIK82178.1|
    Protein
  • N-Terminal Acetyltransferase C
    N-Terminal Acetyltransferase C
    An N-terminal acetyltransferase subtype that consists of the Naa30p catalytic subunit, and the Naa35p and Naa38p auxiliary subunits. It has specificity for the N-terminal METH...<br/>Year introduced: 2013
    MeSH
  • N,N-Dimethyltryptamine
    N,N-Dimethyltryptamine
    An N-methylated indoleamine derivative and serotonergic hallucinogen which occurs naturally and ubiquitously in several plant species including Psychotria veridis. It also occ...<br/>Year introduced: 1991(1989)
    MeSH

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004571375Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Feb 20, 2023)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular defects in the alpha-N-acetylglucosaminidase gene in Italian Sanfilippo type B patients.

Tessitore A, Villani GR, Di Domenico C, Filocamo M, Gatti R, Di Natale P.

Hum Genet. 2000 Dec;107(6):568-76.

PubMed [citation]
PMID:
11153910

Utilizing ExAC to assess the hidden contribution of variants of unknown significance to Sanfilippo Type B incidence.

Clark WT, Yu GK, Aoyagi-Scharber M, LeBowitz JH.

PLoS One. 2018;13(7):e0200008. doi: 10.1371/journal.pone.0200008.

PubMed [citation]
PMID:
29979746
PMCID:
PMC6034809
See all PubMed Citations (6)

Details of each submission

From Invitae, SCV004571375.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This sequence change creates a premature translational stop signal (p.Glu336*) in the NAGLU gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 408 amino acid(s) of the NAGLU protein. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with mucopolysaccharidosis type III (PMID: 11153910). ClinVar contains an entry for this variant (Variation ID: 370575). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects NAGLU function (PMID: 11153910, 29979746). This variant disrupts a region of the NAGLU protein in which other variant(s) (p.Arg626*) have been determined to be pathogenic (PMID: 8650226, 9832037, 10094189). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 5, 2024